Advances in molecular, genetic and immune signatures of gastric cancer: Are we ready to apply them in our patients’ decision making?

doi:10.4251/wjgo.v10.i7.172

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5466)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-2) series.

Item

Count

PDF

368

WORD

258

HTML

2804

Tables (1-2)

147

Sum=3577

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

912

Download

977

Sum=1889

Jul 15, 2018 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastrointest Oncol. Jul 15, 2018; 10(7): 172-183
Published online Jul 15, 2018. doi: 10.4251/wjgo.v10.i7.172

Table 1 Molecular subtypes of gastric cancer according to the Cancer Genome Atlas and Asian Cancer Research Group

Molecular subtypes of gastric cancer
TCGA	ACRG

CIN (50%)	MSS/TP53− (35.7%)
MSI-Η (21%)	MSS/TP53+ (26.3%)
GS (20%)	MSI-H (22.7%)
EBV + (9%)	MSS-EMT (15.3%)

TCGA: Cancer Genome Atlas; ACRG: Asian Cancer Research Group; CIN: Chrosomal instability; MSI-Η: Microsatellite-high; GS: Genomically stable; EBV: Epstein-Barr virus; MSS: Microsatellite stable; TP53: Tumor protein p53; EMT: Epithelial-mesenchymal transition.

Citation: Gkolfinopoulos S, Papamichael D, Papadimitriou K, Papanastasopoulos P, Vassiliou V, Kountourakis P. Advances in molecular, genetic and immune signatures of gastric cancer: Are we ready to apply them in our patients’ decision making? World J Gastrointest Oncol 2018; 10(7): 172-183
URL: https://www.wjgnet.com/1948-5204/full/v10/i7/172.htm
DOI: https://dx.doi.org/10.4251/wjgo.v10.i7.172